| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $27,468,097 ) (Continued on the next page) |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | U01AI148117 | Role of immune receptor clustering in controlling efficacy of antibody-dependent Fc?RIIIa-mediated cytotoxicity by NK cells | 000 | 5 | NIH | 12/14/2023 | $448,802 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244749 | Multifunctional Regulation of Prostate Cancer Metabolism by Sigma1 Modulators | 001 | 5 | NIH | 4/17/2024 | $31,461 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244749 | Multifunctional Regulation of Prostate Cancer Metabolism by Sigma1 Modulators | 000 | 5 | NIH | 12/8/2023 | $566,281 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA238241 | Microbubble Cavitation for Improving Hepatocellular Carcinoma Radioembolization | 001 | 5 | NIH | 4/17/2024 | $16,811 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA238241 | Microbubble Cavitation for Improving Hepatocellular Carcinoma Radioembolization | 000 | 5 | NIH | 11/14/2023 | $302,610 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI141787 | Local?immune?tolerance?in?the?large?intestine?mediated?by?GPR15 | 000 | 5 | NIH | 1/26/2024 | $492,284 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37CA234239 | Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast | 001 | 5 | NIH | 4/18/2024 | $17,843 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37CA234239 | Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast | 000 | 5 | NIH | 12/1/2023 | $321,165 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 000 | 6 | NIH | 1/29/2024 | $330,091 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 002 | 6 | NIH | 2/27/2024 | $26,633 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 001 | 6 | NIH | 2/23/2024 | $119,969 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 003 | 6 | NIH | 4/22/2024 | $18,340 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236853 | BCLW in lymphoma survival and resistance to targeted BCL2 family therapies | 001 | 5 | NIH | 4/23/2024 | $18,697 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236853 | BCLW in lymphoma survival and resistance to targeted BCL2 family therapies | 000 | 5 | NIH | 11/29/2023 | $336,543 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | UG1CA233341 | Sidney Kimmel Cancer Center LAPS Institutional Collaboration | 002 | 5 | NIH | 4/1/2024 | $380,617 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01MH116463 | mGluR5 hypoactivity is integral to glutamatergic dysregulation in schizophrenia | 000 | 6 | NIH | 1/25/2024 | $548,350 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DE033025 | Investigating a new vulnerability in oral squamous cell carcinoma | 000 | 2 | NIH | 4/1/2024 | $469,754 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM149825 | Mechanism for post-transcriptional gene regulation by Ribothrypsis | 000 | 2 | NIH | 3/11/2024 | $294,840 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI173837 | Skin-homing Group-1 innate lymphoid cells in viral defense | 000 | 2 | NIH | 11/2/2023 | $175,500 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21CA273838 | Acoustic Droplet Initiated Radiosensitivity of Hepatocellular Carcinoma | 001 | 2 | NIH | 4/17/2024 | $10,940 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21CA273838 | Acoustic Droplet Initiated Radiosensitivity of Hepatocellular Carcinoma | 000 | 2 | NIH | 3/12/2024 | $196,911 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30NS130973 | Determining the cellular and nanoscale localization of Synaptotagmin VII | 000 | 2 | NIH | 11/9/2023 | $48,969 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL164941 | Crosstalk Ca2+ Signaling between Ryanodine Receptors Type 1 and 2 in the Pathogenesis of Cardiac Hypertrophy and Heart Failure | 000 | 2 | NIH | 3/8/2024 | $511,596 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AG082005 | The tRNA pool in C9-ALS/FTD | 000 | 2 | NIH | 3/18/2024 | $175,909 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM144553 | Crosstalk between DNA repair pathways in repeat instability | 000 | 2 | NIH | 12/12/2023 | $280,800 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R00AG066938 | Molecular mechanisms of Werner syndrome helicase in genome stability and aging | 001 | 4 | NIH | 1/26/2024 | $224,100 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA269750 | Multi-modality detection of RCC Recurrence Post Ablation | 001 | 2 | NIH | 4/22/2024 | $29,227 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA269750 | Multi-modality detection of RCC Recurrence Post Ablation | 000 | 2 | NIH | 11/30/2023 | $526,094 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R03HD110812 | A cell model of YARS2-associated childhood-onset mitochondrial disease | 000 | 2 | NIH | 1/22/2024 | $75,730 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM147191 | From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors | 000 | 3 | NIH | 4/17/2024 | $351,000 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01ES033197 | METTL3 in chromium-induced angiogenesis and carcinogenesis | 000 | 3 | NIH | 1/31/2024 | $519,475 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA262570 | Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer | 001 | 3 | NIH | 4/8/2024 | $564,525 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA263506 | MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response | 001 | 3 | NIH | 4/22/2024 | $32,241 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA263506 | MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response | 000 | 3 | NIH | 3/26/2024 | $232,055 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 001 | 3 | NIH | 4/18/2024 | $27,067 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 000 | 3 | NIH | 12/22/2023 | $487,186 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI160189 | IL-37: a novel regulator of inflammation in CNS autoimmunity | 000 | 3 | NIH | 2/29/2024 | $351,000 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01GM138943 | Regulation of Mutationally Activated Gq/11 | 000 | 4 | NIH | 1/22/2024 | $280,800 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK125897 | ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease | 000 | 4 | NIH | 1/26/2024 | $429,469 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI156384 | Role of IL-7R in CNS autoimmunity | 000 | 3 | NIH | 11/13/2023 | $351,000 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 001 | 4 | NIH | 4/18/2024 | $17,843 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 000 | 4 | NIH | 12/14/2023 | $321,165 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS112504 | Investigating the Role and Regulation of the MAP7 Family Proteins in Axonal Morphogenesis and Function | 000 | 4 | NIH | 12/26/2023 | $385,296 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | F30DK127639 | Silencing the uroguanylin-GUCY2C gut-brain axis mediates leptin resistance in obesity | 000 | 4 | NIH | 12/13/2023 | $48,944 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI152251 | Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity | 000 | 4 | NIH | 2/22/2024 | $351,000 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI146235 | T cell control of MCMV and tissue-localized immune suppression | 001 | 5 | NIH | 3/29/2024 | $0 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI146235 | T cell control of MCMV and tissue-localized immune suppression | 000 | 5 | NIH | 2/12/2024 | $477,173 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY035771 | Molecular function of extracellular vimentin in regulating the response to lens wounding | 000 | 1 | NIH | 2/29/2024 | $480,805 |
| | 2024 | 2024 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21CA286339 | Ligand-Induced Recruitment of CAR-T Cells to Colorectal Cancers | 000 | 1 | NIH | 12/15/2023 | $218,790 |
|
